Global Lapatinib Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 13-Sep-2019
No. of pages: 104

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.

Scope of the Report:

The global Lapatinib market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lapatinib.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Lapatinib market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lapatinib market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 250 mg Tablets

- Type II

Market Segment by Applications, can be divided into

- Hospital

- Drug store

Global Lapatinib Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Lapatinib Market Overview
1.1 Product Overview and Scope of Lapatinib
1.2 Classification of Lapatinib by Types
1.2.1 Global Lapatinib Revenue Comparison by Types (2019-2024)
1.2.2 Global Lapatinib Revenue Market Share by Types in 2018
1.2.3 250 mg Tablets
1.2.4 Type II
1.3 Global Lapatinib Market by Application
1.3.1 Global Lapatinib Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Lapatinib Market by Regions
1.4.1 Global Lapatinib Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Lapatinib Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lapatinib Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lapatinib Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Lapatinib Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lapatinib Status and Prospect (2014-2024)
1.5 Global Market Size of Lapatinib (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Lapatinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Lapatinib Revenue, Gross Margin and Market Share (2017-2018)
3 Global Lapatinib Market Competition, by Players
3.1 Global Lapatinib Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Lapatinib Players Market Share
3.2.2 Top 10 Lapatinib Players Market Share
3.3 Market Competition Trend
4 Global Lapatinib Market Size by Regions
4.1 Global Lapatinib Revenue and Market Share by Regions
4.2 North America Lapatinib Revenue and Growth Rate (2014-2019)
4.3 Europe Lapatinib Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Lapatinib Revenue and Growth Rate (2014-2019)
4.5 South America Lapatinib Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Lapatinib Revenue and Growth Rate (2014-2019)
5 North America Lapatinib Revenue by Countries
5.1 North America Lapatinib Revenue by Countries (2014-2019)
5.2 USA Lapatinib Revenue and Growth Rate (2014-2019)
5.3 Canada Lapatinib Revenue and Growth Rate (2014-2019)
5.4 Mexico Lapatinib Revenue and Growth Rate (2014-2019)
6 Europe Lapatinib Revenue by Countries
6.1 Europe Lapatinib Revenue by Countries (2014-2019)
6.2 Germany Lapatinib Revenue and Growth Rate (2014-2019)
6.3 UK Lapatinib Revenue and Growth Rate (2014-2019)
6.4 France Lapatinib Revenue and Growth Rate (2014-2019)
6.5 Russia Lapatinib Revenue and Growth Rate (2014-2019)
6.6 Italy Lapatinib Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Lapatinib Revenue by Countries
7.1 Asia-Pacific Lapatinib Revenue by Countries (2014-2019)
7.2 China Lapatinib Revenue and Growth Rate (2014-2019)
7.3 Japan Lapatinib Revenue and Growth Rate (2014-2019)
7.4 Korea Lapatinib Revenue and Growth Rate (2014-2019)
7.5 India Lapatinib Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Lapatinib Revenue and Growth Rate (2014-2019)
8 South America Lapatinib Revenue by Countries
8.1 South America Lapatinib Revenue by Countries (2014-2019)
8.2 Brazil Lapatinib Revenue and Growth Rate (2014-2019)
8.3 Argentina Lapatinib Revenue and Growth Rate (2014-2019)
8.4 Colombia Lapatinib Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Lapatinib by Countries
9.1 Middle East and Africa Lapatinib Revenue by Countries (2014-2019)
9.2 Saudi Arabia Lapatinib Revenue and Growth Rate (2014-2019)
9.3 UAE Lapatinib Revenue and Growth Rate (2014-2019)
9.4 Egypt Lapatinib Revenue and Growth Rate (2014-2019)
9.5 Nigeria Lapatinib Revenue and Growth Rate (2014-2019)
9.6 South Africa Lapatinib Revenue and Growth Rate (2014-2019)
10 Global Lapatinib Market Segment by Type
10.1 Global Lapatinib Revenue and Market Share by Type (2014-2019)
10.2 Global Lapatinib Market Forecast by Type (2019-2024)
10.3 250 mg Tablets Revenue Growth Rate (2014-2024)
10.4 Type II Revenue Growth Rate (2014-2024)
11 Global Lapatinib Market Segment by Application
11.1 Global Lapatinib Revenue Market Share by Application (2014-2019)
11.2 Lapatinib Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Lapatinib Market Size Forecast (2019-2024)
12.1 Global Lapatinib Market Size Forecast (2019-2024)
12.2 Global Lapatinib Market Forecast by Regions (2019-2024)
12.3 North America Lapatinib Revenue Market Forecast (2019-2024)
12.4 Europe Lapatinib Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Lapatinib Revenue Market Forecast (2019-2024)
12.6 South America Lapatinib Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Lapatinib Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Lapatinib Picture
Table Product Specifications of Lapatinib
Table Global Lapatinib and Revenue (Million USD) Market Split by Product Type
Figure Global Lapatinib Revenue Market Share by Types in 2018
Figure 250 mg Tablets Picture
Figure Type II Picture
Table Global Lapatinib Revenue (Million USD) by Application (2014-2024)
Figure Lapatinib Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Lapatinib Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Lapatinib Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Lapatinib Type and Applications
Table Novartis Lapatinib Revenue, Gross Margin and Market Share (2017-2018)
Table Global Lapatinib Revenue (Million USD) by Players (2014-2019)
Table Global Lapatinib Revenue Share by Players (2014-2019)
Figure Global Lapatinib Revenue Share by Players in 2017
Figure Global Lapatinib Revenue Share by Players in 2018
Figure Global Top 5 Players Lapatinib Revenue Market Share in 2018
Figure Global Top 10 Players Lapatinib Revenue Market Share in 2018
Figure Global Lapatinib Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Lapatinib Revenue (Million USD) by Regions (2014-2019)
Table Global Lapatinib Revenue Market Share by Regions (2014-2019)
Figure Global Lapatinib Revenue Market Share by Regions (2014-2019)
Figure Global Lapatinib Revenue Market Share by Regions in 2018
Figure North America Lapatinib Revenue and Growth Rate (2014-2019)
Figure Europe Lapatinib Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Lapatinib Revenue and Growth Rate (2014-2019)
Figure South America Lapatinib Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Lapatinib Revenue and Growth Rate (2014-2019)
Table North America Lapatinib Revenue by Countries (2014-2019)
Table North America Lapatinib Revenue Market Share by Countries (2014-2019)
Figure North America Lapatinib Revenue Market Share by Countries (2014-2019)
Figure North America Lapatinib Revenue Market Share by Countries in 2018
Figure USA Lapatinib Revenue and Growth Rate (2014-2019)
Figure Canada Lapatinib Revenue and Growth Rate (2014-2019)
Figure Mexico Lapatinib Revenue and Growth Rate (2014-2019)
Table Europe Lapatinib Revenue (Million USD) by Countries (2014-2019)
Figure Europe Lapatinib Revenue Market Share by Countries (2014-2019)
Figure Europe Lapatinib Revenue Market Share by Countries in 2018
Figure Germany Lapatinib Revenue and Growth Rate (2014-2019)
Figure UK Lapatinib Revenue and Growth Rate (2014-2019)
Figure France Lapatinib Revenue and Growth Rate (2014-2019)
Figure Russia Lapatinib Revenue and Growth Rate (2014-2019)
Figure Italy Lapatinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Lapatinib Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Lapatinib Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Lapatinib Revenue Market Share by Countries in 2018
Figure China Lapatinib Revenue and Growth Rate (2014-2019)
Figure Japan Lapatinib Revenue and Growth Rate (2014-2019)
Figure Korea Lapatinib Revenue and Growth Rate (2014-2019)
Figure India Lapatinib Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Lapatinib Revenue and Growth Rate (2014-2019)
Table South America Lapatinib Revenue by Countries (2014-2019)
Table South America Lapatinib Revenue Market Share by Countries (2014-2019)
Figure South America Lapatinib Revenue Market Share by Countries (2014-2019)
Figure South America Lapatinib Revenue Market Share by Countries in 2018
Figure Brazil Lapatinib Revenue and Growth Rate (2014-2019)
Figure Argentina Lapatinib Revenue and Growth Rate (2014-2019)
Figure Colombia Lapatinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Lapatinib Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Lapatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lapatinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Lapatinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Lapatinib Revenue and Growth Rate (2014-2019)
Figure UAE Lapatinib Revenue and Growth Rate (2014-2019)
Figure Egypt Lapatinib Revenue and Growth Rate (2014-2019)
Figure Nigeria Lapatinib Revenue and Growth Rate (2014-2019)
Figure South Africa Lapatinib Revenue and Growth Rate (2014-2019)
Table Global Lapatinib Revenue (Million USD) by Type (2014-2019)
Table Global Lapatinib Revenue Share by Type (2014-2019)
Figure Global Lapatinib Revenue Share by Type (2014-2019)
Figure Global Lapatinib Revenue Share by Type in 2019
Table Global Lapatinib Revenue Forecast by Type (2019-2024)
Figure Global Lapatinib Market Share Forecast by Type (2019-2024)
Figure Global 250 mg Tablets Revenue Growth Rate (2014-2019)
Figure Global Type II Revenue Growth Rate (2014-2019)
Table Global Lapatinib Revenue by Application (2014-2019)
Table Global Lapatinib Revenue Share by Application (2014-2019)
Figure Global Lapatinib Revenue Share by Application (2014-2019)
Figure Global Lapatinib Revenue Share by Application in 2019
Table Global Lapatinib Revenue Forecast by Application (2019-2024)
Figure Global Lapatinib Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Lapatinib Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Lapatinib Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Lapatinib Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Lapatinib Revenue Market Forecast (2019-2024)
Figure Europe Lapatinib Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Lapatinib Revenue Market Forecast (2019-2024)
Figure South America Lapatinib Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Lapatinib Revenue Market Forecast (2019-2024)
  • Global Anxiolytics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 115
    An anxiolytic is a medication or other intervention that inhibits anxiety. Scope of the Report: The worldwide market for Anxiolytics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Anxiolytics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. ......
  • Global Antipsychotic Medications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 116
    Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions. Scope of the Report: The worldwide market for Antipsychotic Medications is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antipsychotic......
  • Global Prescription Respiratory Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 102
    A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Scope of the Report: The worldwide market for Prescription Respiratory Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Prescription Respiratory Drugs in global market, especially in North Ame......
  • Global Intravenous Anesthetics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 117
    Intravenous anesthetics are used to induce a state of impaired awareness or for complete sedation. Scope of the Report: The worldwide market for Intravenous Anesthetics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Intravenous Anesthetics in global market, especially in North America, Europe and Asia-......
  • Global Inhalational Anesthesia Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 123
    An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation. Scope of the Report: The worldwide market for Inhalational Anesthesia Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Inhalational Anesthesia Drugs in global market, e......
  • Global Pharmaceutical Excipients for Oral Formulations Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 124
    Pharmaceutical excipients that deliver the full potential of your drug and improve patient compliance. Scope of the Report: The worldwide market for Pharmaceutical Excipients for Oral Formulations is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pharmaceutical Excipients for Oral Formulations in global m......
  • Global Adult and Pediatric Vaccines Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 115
    A vaccine is a biological preparation that provides active acquired immunity to a particular disease. Scope of the Report: The global Adult and Pediatric Vaccines market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North ......
  • Global Direct-to-consumer Disease Risk and Health Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 138
    The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person's carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Direct-to-consumer Disease Risk and ......
  • Global Disease Risk and Health Test Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    Published: 23-Sep-2019        Price: US 3480 Onwards        Pages: 136
    The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person's carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. Scope of the Report: The global Disease Risk and Health Test market ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs